相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer
P. Heudel et al.
ESMO OPEN (2021)
Delayed immune-related adverse events with an PD-1-based immunotherapy in melanoma
C. N. Owen et al.
ANNALS OF ONCOLOGY (2021)
PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects
Enrico Munari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Immuno-oncology: a narrative review of gastrointestinal and hepatic toxicities
Stergios Boussios et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Harnessing cancer immunotherapy during the unexploited immediate perioperative period
Pini Matzner et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies
Anita Mazloom et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Perioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer
Brendon M. Stiles et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Assessment of Trends in Second Primary Cancers in Patients With Metastatic Melanoma From 2005 to 2016
Weiye Deng et al.
JAMA NETWORK OPEN (2020)
Immune checkpoint inhibitors in genitourinary malignancies
M. Thana et al.
CURRENT ONCOLOGY (2020)